Viral Genetics viralgenetics.com


Viral Genetics is a Healthcare/Biotechnology company based in San Marino, California. Viral Genetics' investors include DKR Capital, Nite Capital Management, PEF Advisors, N.I.R. Group, Beacon Fund Advisors and SIBEX Capital Fund.

Viral Genetics is a Healthcare/Biotechnology company based in San Marino, California. Viral Genetics' investors include DKR Capital, Nite Capital Management, PEF Advisors, N.I.R. Group, Beacon Fund Advisors and SIBEX Capital Fund.

Company (IPO / Went public)

Phone: 626-334-5310

Fax:

2290 Huntington Drive
Suite 100
San Marino, 91108
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Viral Genetics $2.9M Aug 23, 2006

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Viral Genetics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Nite Capital ManagementPrivate EquityLibertyville, Illinois, United StatesUnattributed VC
DKR CapitalAsset/Investment ManagementConnecticut, United StatesUnattributed VC
PEF AdvisorsAdvisoryRoswell, Georgia, United StatesUnattributed VC
Beacon Fund AdvisorsAdvisorySouth Carolina, Virgin Islands (British)Unattributed VC
N.I.R. GroupHedge FundRoslyn, New York, United StatesUnattributed VC
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and products for treating preeclampsia and modulating blood pressure Nov 30, 2012 Jun 07, 2016 Patent
Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei Jan 03, 2003 Dec 01, 2009 Patent